Last updated: 2026-09-23 11:44:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
AtaiBeckley Inc. (ATAI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $7.36, with a market capitalization of $2.73B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.27 to $7.45. This page covers its latest market performance, valuation, price trends and company information.
$2.73B | |
$7.31 | |
$22.91 | |
$0.82 | |
$7.29 | |
8.79M | |
14.37M | |
-- | |
$7.45 | |
$3.27 | |
-- | |
-- |
AtaiBeckley Inc. (ATAI) is trading at $7.31 in pre-market trading as of 2026-09-10 23:49:00, up 0.23% ($0.02) from the previous close of $7.29
Pre-market trading shows how investors are pricing ATAI before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, AtaiBeckley Inc. (ATAI) moved from $7.34 to $7.36, representing a gain of 0.20% ($0.02).
The stock traded between $7.23 and $7.43 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 26.92 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 97.7%
ATAI is currently trading at $7.36, placing it 97.7% of the way from its 52-week low of $3.27 to its 52-week high of $7.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 99 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AtaiBeckley Inc. (ATAI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.